Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Local recurrence of breast cancer after mastectomy and modern multidisciplinary treatment.

Siponen ET, Joensuu H, Leidenius MH.

Acta Oncol. 2013 Jan;52(1):66-72. doi: 10.3109/0284186X.2012.718793. Epub 2012 Sep 13.

PMID:
22971019
2.

[Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].

Wang SL, Li YX, Song YW, Wang WH, Jin J, Liu YP, Liu XF, Yu ZH.

Zhonghua Zhong Liu Za Zhi. 2010 Jul;32(7):520-5. Chinese.

PMID:
21029696
3.

Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy.

Margalit DN, Sreedhara M, Chen YH, Catalano PJ, Nguyen PL, Golshan M, Overmoyer BA, Harris JR, Brock JE.

Ann Surg Oncol. 2013 Mar;20(3):811-8. doi: 10.1245/s10434-012-2640-8. Epub 2012 Sep 7.

PMID:
22956068
4.

Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.

Touboul E, Buffat L, Belkacémi Y, Lefranc JP, Uzan S, Lhuillier P, Faivre C, Huart J, Lotz JP, Antoine M, Pène F, Blondon J, Izrael V, Laugier A, Schlienger M, Housset M.

Int J Radiat Oncol Biol Phys. 1999 Jan 1;43(1):25-38.

PMID:
9989511
5.

Breast cancer in very young women.

Liukkonen S, Leidenius M, Saarto T, Sjöström-Mattson J.

Eur J Surg Oncol. 2011 Dec;37(12):1030-7. doi: 10.1016/j.ejso.2011.08.133. Epub 2011 Sep 21.

PMID:
21937191
6.

Outcome of small invasive breast cancer with no axillary lymph node involvement.

Sánchez-Muñoz A, Pérez-Ruiz E, Jurado JM, Ribelles N, Márquez A, Miramón J, Maíz M, Pajares B, Gallego E, Scholtz V, Jiménez B, Soler C, Molina M, García-Ríos I, Alba E.

Breast J. 2011 Jan-Feb;17(1):32-8. doi: 10.1111/j.1524-4741.2010.01026.x. Epub 2010 Dec 6.

PMID:
21129091
7.

Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment.

Milgrom S, Cody H, Tan L, Morrow M, Pesce C, Setton J, Rogers K, Arnold B, Eaton A, Catalano J, McCormick B, Powell S, Ho A.

Ann Surg Oncol. 2012 Nov;19(12):3762-70. doi: 10.1245/s10434-012-2386-3. Epub 2012 May 11.

PMID:
22576064
8.

Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis.

Willner J, Kiricuta IC, Kölbl O.

Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):853-63.

PMID:
9128962
9.

Prognostic significance of local recurrence in breast cancer after postmastectomy radiotherapy.

Dunst J, Steil B, Furch S, Fach A, Lautenschläger C, Diestelhorst A, Lampe D, Kölbl H, Richter C.

Strahlenther Onkol. 2001 Oct;177(10):504-10.

PMID:
11680014
10.

259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.

Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M.

Breast Cancer Res Treat. 2008 Jun;109(3):405-16. Epub 2007 Aug 9. Review.

PMID:
17687650
11.

Male breast cancer: a survey at the Helsinki University Central Hospital during 1981-2006.

Liukkonen S, Saarto T, Mäenpää H, Sjöström-Mattson J.

Acta Oncol. 2010 Apr;49(3):322-7. doi: 10.3109/02841861003591723.

PMID:
20397767
12.
13.

Prognosis following local recurrence after breast conserving treatment in young women with early breast cancer.

van der Sangen MJ, Poortmans PM, Scheepers SW, Lemaire BM, van Berlo CL, Tjan-Heijnen VC, Voogd AC.

Eur J Surg Oncol. 2013 Aug;39(8):892-8. doi: 10.1016/j.ejso.2013.05.004. Epub 2013 May 30.

PMID:
23726902
14.

Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.

Yegiyants S, Romero LM, Haigh PI, DiFronzo LA.

Arch Surg. 2010 Jun;145(6):564-9. doi: 10.1001/archsurg.2010.84.

PMID:
20566977
15.

Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC-ESTRO Breast Cancer Working Group.

Hannoun-Levi JM, Resch A, Gal J, Kauer-Dorner D, Strnad V, Niehoff P, Loessl K, Kovács G, Van Limbergen E, Polgár C; GEC-ESTRO Breast Cancer Working Group.

Radiother Oncol. 2013 Aug;108(2):226-31. doi: 10.1016/j.radonc.2013.03.026. Epub 2013 May 3.

PMID:
23647758
16.

[Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].

Zhang P, Xu BH, Ma F, Li Q, Yuan P, Wang JY, Zhang P.

Zhonghua Zhong Liu Za Zhi. 2011 May;33(5):381-4. Chinese.

PMID:
21875471
17.

Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant tamoxifen alone: patterns of recurrence.

Fisher BJ, Perera FE, Cooke AL, Opeitum A, Stitt L.

Int J Radiat Oncol Biol Phys. 1998 Aug 1;42(1):117-23.

PMID:
9747828
18.
19.

Local recurrence after mastectomy for breast cancer: analysis of clinicopathological, biological and prognostic characteristics.

Carreño G, Del Casar JM, Corte MD, González LO, Bongera M, Merino AM, Juan G, Obregón R, Martínez E, Vizoso FJ.

Breast Cancer Res Treat. 2007 Mar;102(1):61-73. Epub 2006 Jul 19.

PMID:
16850244
20.

Outcome of treatment for ipsilateral breast tumor recurrence in early-stage breast cancer.

Dalberg K, Mattsson A, Sandelin K, Rutqvist LE.

Breast Cancer Res Treat. 1998 May;49(1):69-78.

PMID:
9694613

Supplemental Content

Support Center